Robert Hoffman

Performance

Overall performance
0.5

Performance over holding periods
0.5
30 days 90 days 120 days
Average return -23% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Chairman of the Board TuHURA Biosciences Inc June 2, 2018 -
Chief Financial Officer, Senior Vice President - Finance Heron Therapeutics Inc April 1, 2017 -
Independent Chairman of the Board TuHURA Biosciences Inc June 2, 2018 -
Independent Director CombiMatrix Corp July 15, 2013 -
Independent Director Kura Oncology Inc March 1, 2015 -
Independent Director Aravive Inc Oct. 12, 2018 - April 8, 2020
Independent Director TuHURA Biosciences Inc None -
Independent Director MabVax Therapeutics Holdings Inc Sept. 8, 2014 - Dec. 31, 2017
Chief Financial Officer, Executive Vice President, Principal Accounting Officer Innovus Pharmaceuticals Inc Sept. 6, 2016 - April 21, 2017
Chief Financial Officer, Senior Vice President - Finance Arena Pharmaceuticals Inc June 15, 2012 - July 10, 2015
Chief Financial Officer, Vice President - Finance Arena Pharmaceuticals Inc Aug. 29, 2011 - June 15, 2012

Robert Hoffman's trades of TuHURA Biosciences Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-02-17 2022-02-15 B Purchase
39,993 -25.2%
453.50
US$1,239,369
39,993 -25.2% 453.50 US$1,239,369